{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:58:34Z","timestamp":1790521114479,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"DOI":"10.1371\/journal.pbio.2005046","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T13:24:16Z","timestamp":1536067456000},"page":"e2005046","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":110,"title":["The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation"],"prefix":"10.1371","volume":"16","author":[{"given":"Konstantin","family":"Knoblich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cruz Migoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Siew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baksho","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfie T.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muath","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Vrzalikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Mehenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye H.","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Hirschfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Parekkadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon J.","family":"Turley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-1142","authenticated-orcid":true,"given":"Anne L.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nri3846","article-title":"Lymph node fibroblastic reticular cells in health and disease","volume":"15","author":"AL Fletcher","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ni1513","article-title":"Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells","volume":"8","author":"A Link","year":"2007","journal-title":"Nat Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ni.2965","article-title":"B cell homeostasis and follicle confines are governed by fibroblastic reticular cells","volume":"15","author":"V Cremasco","year":"2014","journal-title":"Nat Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1038\/s41598-017-03459-5","article-title":"Fibroblastic reticular cells of the lymphoid tissues modulate T cell activation threshold during homeostasis via hyperactive cyclooxygenase-2\/prostaglandin E2axis","volume":"7","author":"M Yu","year":"2017","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ni.2112","article-title":"Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes","volume":"12","author":"V Lukacs-Kornek","year":"2011","journal-title":"Nat Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e27618","DOI":"10.1371\/journal.pone.0027618","article-title":"Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide","volume":"6","author":"S Siegert","year":"2011","journal-title":"PLoS ONE"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e26138","DOI":"10.1371\/journal.pone.0026138","article-title":"Regulation of T cell priming by lymphoid stroma","volume":"6","author":"O Khan","year":"2011","journal-title":"PLoS ONE"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.ajpath.2010.12.039","article-title":"Association of T-Zone Reticular Networks and Conduits with Ectopic Lymphoid Tissues in Mice and Humans","volume":"178","author":"A Link","year":"2011","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jcyt.2017.01.010","article-title":"Characterization of human fibroblastic reticular cells as potential immunotherapeutic tools","volume":"19","author":"J Valencia","year":"2017","journal-title":"Cytotherapy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"12139","DOI":"10.1073\/pnas.1412910111","article-title":"Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells","volume":"111","author":"AE Denton","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"249ra109","DOI":"10.1126\/scitranslmed.3009377","article-title":"Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis","volume":"6","author":"AL Fletcher","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0702579104","article-title":"Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection","volume":"104","author":"SN Mueller","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2011.00035","article-title":"Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells","volume":"2","author":"AL Fletcher","year":"2011","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni.2262","article-title":"Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks","volume":"13","author":"D Malhotra","year":"2012","journal-title":"Nat Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.immuni.2018.04.006","article-title":"Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity","volume":"48","author":"LB Rodda","year":"2018","journal-title":"Immunity"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.0900835","article-title":"Fluid Flow Regulates Stromal Cell Organization and CCL21 Expression in a Tissue-Engineered Lymph Node Microenvironment","volume":"183","author":"AA Tomei","year":"2009","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.4049\/jimmunol.179.3.1595","article-title":"Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells","volume":"179","author":"MA Haniffa","year":"2007","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"JN Kochenderfer","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/1078-0432.CCR-16-1365","article-title":"Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial","volume":"23","author":"C-M Wang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4049\/jimmunol.1000108","article-title":"Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology","volume":"185","author":"PB Ernst","year":"2010","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/icb.2011.75","article-title":"Prostaglandin E2 and T cells: friends or foes?","volume":"90","author":"V Sreeramkumar","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/ar3871","article-title":"Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action","volume":"14","author":"LK Stamp","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.csbj.2015.03.008","article-title":"A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy","volume":"13","author":"RD Leone","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"ref24","article-title":"T Cell Receptor-Regulated TGF-\u03b2 Type I Receptor Expression Determines T Cell Quiescence and Activation","author":"E Tu","year":"2018","journal-title":"Immunity"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1308616","article-title":"Blockade of only TGF-\u03b2 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy","volume":"6","author":"M Terabe","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.20092642","article-title":"Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions","volume":"207","author":"AL Fletcher","year":"2010","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/jp2082825","article-title":"Complete Reaction Mechanism of Indoleamine 2,3-Dioxygenase as Revealed by QM\/MM Simulations","volume":"116","author":"L Capece","year":"2012","journal-title":"J Phys Chem B"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"C Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"ref29","first-page":"67","article-title":"The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy","volume":"9","author":"J-P Routy","year":"2016","journal-title":"Int J Tryptophan Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molimm.2016.11.018","article-title":"Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1\/Rac pathway","volume":"81","author":"R Li","year":"2017","journal-title":"Mol Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4161\/cbt.8.14.8882","article-title":"IDO inhibits T-cell function through suppressing Vav1 expression and activation","volume":"8","author":"R Li","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"ref32","article-title":"Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance","author":"M Hennequart","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"DH Munn","year":"1999","journal-title":"J Exp Med"},{"issue":"50","key":"ref34","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","author":"EM Smyth","year":"2009","journal-title":"J Lipid Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1172\/JCI106510","article-title":"Cyclic adenosine 3\u2032,5\u2032-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation","volume":"50","author":"JW Smith","year":"1971","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.4049\/jimmunol.1103090","article-title":"Prostaglandin E2 affects T cell responses through modulation of CD46 expression","volume":"188","author":"K Kickler","year":"2012","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4049\/jimmunol.175.3.1483","article-title":"Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells","volume":"175","author":"F Baratelli","year":"2005","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"C Cekic","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.22.012703.104731","article-title":"Physiological Control of Immune Response and Inflammatory Tissue Damage by Hypoxia-Inducible Factors and Adenosine A <sub>2A<\/sub> Receptors","volume":"22","author":"M V Sitkovsky","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref40","article-title":"A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced Immunosuppression","author":"J Kjaergaard","year":"2018","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.4049\/jimmunol.167.11.6140","article-title":"Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions","volume":"167","author":"CC Caldwell","year":"2001","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","article-title":"Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia","volume":"15","author":"A Carreau","year":"2011","journal-title":"J Cell Mol Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1016\/j.febslet.2015.07.027","article-title":"CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression","volume":"589","author":"MR Bono","year":"2015","journal-title":"FEBS Lett"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1096\/fj.13-241646","article-title":"Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2\/3","volume":"28","author":"M Perez-Aso","year":"2014","journal-title":"FASEB J"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.1301843","article-title":"TGF-\u03b2: guardian of T cell function","volume":"191","author":"SA Oh","year":"2013","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"L Yang","year":"2010","journal-title":"Trends Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-\u03b21 gene results in multifocal inflammatory disease","volume":"359","author":"MM Shull","year":"1992","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1001-1118","article-title":"Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells","volume":"7","author":"L Gorelik","year":"2001","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-\u03b2: A Master of All T Cell Trades","volume":"134","author":"MO Li","year":"2008","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-\u03b2 directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"DA Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-3083.2003.01297.x","article-title":"Transforming Growth Factor-beta as a Regulator of Site-Specific T-Cell Inflammatory Response","volume":"58","author":"BR Ludviksson","year":"2003","journal-title":"Scand J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbi.2014.07.022","article-title":"Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system","volume":"43","author":"J Wang","year":"2015","journal-title":"Brain Behav Immun"}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pbio.2005046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:26:53Z","timestamp":1589012813000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.2005046"}},"subtitle":[],"editor":[{"given":"Avinash","family":"Bhandoola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.2005046","relation":{},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]}}}